Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡

Cited by (1,007)

Items 901–1,000 of 1,007

1. Application and progress of the detection technologies in hepatocellular carcinoma
   Qi Yan, Yuansong Sun, Ran An, Fang Liu, Fang Qi, Zhen Wang, Tao Xu, Lijian Chen, Jian Du · 2022 · Genes & Diseases
2. Transient elastography for monitoring the fibrosis of non‐alcoholic fatty liver disease for 4 years
   Kaori Suzuki, Masato Yoneda, Kento Imajo, Hiroyuki Kirikoshi, Atsushi Nakajima, Shin Maeda, Satoru Saito · 2012 · Hepatology Research
3. Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions
   Daniel Motola, Peter D. Caravan, Raymond T. Chung, Bryan C. Fuchs · 2014 · Current Pathobiology Reports
4. Association Between Platelet Count as a Noninvasive Marker and Ultrasonographic Grading in Patients With Nonalcoholic Fatty Liver Disease
   Afagh Garjani, Abdolrasoul Safaeiyan, Manouchehr Khoshbaten · 2015 · Hepatitis Monthly
5. Serum levels of tissue inhibitor of metalloproteinase‐1 are correlated with liver fibrosis in patients with chronic hepatitis B
   Chuanlong Zhu, Wen Ting Li, Yi Li, R.T. Gao · 2012 · Journal of Digestive Diseases
6. The relationship between liver histology and noninvasive markers in primary biliary cirrhosis
   Şehmus Ölmez, Süleyman Sayar, Ufuk Avcıoğlu, İlyas Tenlik, Ersan Özaslan, Hasan Tankut Köseoğlu, Emin Altıparmak · 2016 · European Journal of Gastroenterology & Hepatology
7. Combined Preoperative ALBI and FIB-4 Is Associated with Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy
   Rui Liao, Dewei Li, Chengyou Du, Ming Li · 2018 · Journal of Gastrointestinal Surgery
8. Liver fibrosis in children: a comprehensive review of mechanisms, diagnosis, and therapy
   Elif Ozdogan, Çiğdem Arıkan · 2022 · Korean Journal of Pediatrics
9. Prevalence of Steatotic Liver Disease Based on a New Nomenclature in the Japanese Population: A Health Checkup-Based Cross-Sectional Study
   Takao Miwa, Satoko Tajirika, Nanako Imamura, Miho Adachi, Ryo Horita, Tatsunori Hanai, Taku Fukao, Masahito Shimizu, Mayumi Yamamoto · 2024 · Journal of Clinical Medicine
10. Noninvasive liver disease assessment to identify portal hypertension: Systematic and narrative reviews supporting the AASLD Practice Guideline
    Don C. Rockey, Mouaz Alsawas, Andrés Duarte‐Rojo, Keyur Patel, Deborah Levine, Sumeet K. Asrani, Bashar Hasan, Tarek Nayfeh, Yahya Alsawaf, Samer Mohir Saadi et al. · 2024 · Hepatology
11. Circulating fatty acids and risk of hepatocellular carcinoma and chronic liver disease mortality in the UK Biobank
    Zhening Liu, Hangkai Huang, Jiarong Xie, Yingying Xu, Chengfu Xu · 2024 · Nature Communications
12. Non-invasive visualization of liver fibrosis with [68Ga]Ga-DOTA-FAPI-04 PET from preclinical insights to clinical translation
    Yangmeihui Song, Chunxia Qin, Yixiong Chen, Weiwei Ruan, Yongkang Gai, Wenyu Song, Yu Gao, Wenzhu Hu, Pengxin Qiao, Xiangming Song et al. · 2024 · European Journal of Nuclear Medicine and Molecular Imaging
13. A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis B patients
    Beom Kyung Kim, Kwang‐Hyub Han, Jun Yong Park, Sang Hoon Ahn, Chae Yoon Chon, Ja Kyung Kim, Yong Han Paik, Kwan Sik Lee, Young Nyun Park, Do Young Kim · 2010 · Liver International
14. Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score
    Tae Hoon Lee, SeungHye Han, Ju Dong Yang, Donghee Kim, §, Monjur Ahmed∥ · 2013 · Gut and Liver
15. The Diagnostic Accuracy and Clinical Utility of Three Noninvasive Models for Predicting Liver Fibrosis in Patients with HBV Infection
    Zhiqiao Zhang, Gongsui Wang, Kang Kai-fu, Guobiao Wu, Peng Wang · 2016 · PLoS ONE
16. Prevalence and predictors of liver disease in HIV-infected children and adolescents
    Maria Pokorska‐Śpiewak, Aleksandra Stańska-Perka, Jolanta Popielska, Agnieszka Ołdakowska, Urszula Coupland, Konrad Zawadka, Małgorzata Szczepańska-Putz, Magdalena Marczyńska · 2017 · Scientific Reports
17. Reference values of liver volume in Caucasian population and factors influencing liver size
    M. L. Kromrey, Till Ittermann, C. vWahsen, Verena Plodeck, Danilo Seppelt, RT Hoffmann, P. Heiss, Jens‐Peter Kühn · 2018 · European Journal of Radiology
18. Declining in liver stiffness cannot indicate fibrosis regression in patients with chronic hepatitis B: A 78‐week prospective study
    Xiaoqin Dong, Zhao Wu, ­Jun Li­, Gui‐Qiang Wang, Hong Zhao · 2018 · Journal of Gastroenterology and Hepatology
19. Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: A retrospective monocentric study
    Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yong‐Beom Park, Kwang‐Hyub Han, Sang‐Won Lee · 2018 · Modern Rheumatology
20. Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct‐acting antivirals
    Nobuharu Tamaki, Mayu Higuchi, Masayuki Kurosaki, Sakura Kirino, Leona Osawa, Keiya Watakabe, Wan Wang, Mao Okada, Takao Shimizu, Kenta Takaura et al. · 2019 · Journal of Viral Hepatitis
21. Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia
    Kali Zhou, Abdus S. Wahed, Stewart Cooper, Adrian M. Di Bisceglie, Robert J. Fontana, Marc G. Ghany, Mandana Khalili, Anna Suk-Fong Lok, Robert Perrillo, William M. Lee et al. · 2019 · The American Journal of Gastroenterology
22. Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease
    Rafael Paternostro, Jan Pfeiffenberger, Péter Ferenci, Albert Friedrich Stättermayer, Rudolf E Stauber, Fritz Wrba, Thomas Longerich, Karoline Lackner, Michael A Trauner, Arnulf Ferlitsch et al. · 2020 · Liver International
23. HEV‐LFS: A novel scoring model for patients with hepatitis E virus‐related liver failure
    Jian Wu, Naizhou Guo, Xueyan Zhang, Cunquan Xiong, Jun Liu, Yanping Xu, Jun Fan, Jiong Yu, Xinguo Zhao, Bin Liu et al. · 2019 · Journal of Viral Hepatitis
24. Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals
    Albert Do, Denise Ann Esserman, Supriya Krishnan, Joseph K. Lim, Tamar Hamosh Taddei, Ronald George Hauser, Janet P. Tate, Vincent Lo Re, Amy C. Justice · 2020 · Journal of General Internal Medicine
25. Metabolic profiles and fibrosis of nonalcoholic fatty liver disease in the elderly: A community‐based study
    Tsung‐Po Chen, Michelle Lai, Wen‐Yuan Lin, Kuo‐Chin Huang, Kuen‐Cheh Yang · 2020 · Journal of Gastroenterology and Hepatology
26. Outcomes of Hepatitis C Virus Treatment in the New York City Jail Population: Successes and Challenges Facing Scale up of Care
    Justin Chan, Jessie Schwartz, Fatos Kaba, Angelica Bocour, Matthew J. Akiyama, Laura Hobstetter, Zachary Rosner, Ann I. Winters, Patricia Yang, Ross S. MacDonald · 2020 · Open Forum Infectious Diseases
27. TERT Promoter Mutation in Serum Cell-Free DNA Is a Diagnostic Marker of Primary Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
    Norio Akuta, Yusuke Kawamura, Mariko Kobayashi, Yasuji Arase, Satoshi Saitoh, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Yoshiyuki Suzuki et al. · 2020 · Oncology
28. Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases
    Se Young Jang, Won Young Tak, Soo Young Park, Young Oh Kweon, Yu Rim Lee, Gyeonghwa Kim, Keun Hur, Man‐Hoon Han, Won Kee Lee · 2020 · Annals of Laboratory Medicine
29. Comprehensive metabolomics profiling reveals common metabolic alterations underlying the four major non-communicable diseases in treated HIV infection
    Yingying Ding, Haijiang Lin, Xiaoxiao Chen, Bowen Zhu, Xiaohui Xu, Xiaoyi Xu, Weiwei Shen, Meiyang Gao, Na He · 2021 · EBioMedicine
30. The FIB-4 Index Predicts the Development of Liver-Related Events, Extrahepatic Cancers, and Coronary Vascular Disease in Patients with NAFLD
    Yoshihiro Kamada, Kensuke Munekage, Takashi Nakahara, Hideki Fujii, Yoshiyuki Sawai, Yoshinori Doi, Hideyuki Hyogo, Yoshio Sumida, Yasuharu Imai, Eiji Miyoshi et al. · 2022 · Nutrients
31. A deep learning framework for personalised dynamic diagnosis of graft fibrosis after liver transplantation: a retrospective, single Canadian centre, longitudinal study
    Amirhossein Azhie, Divya Sharma, Priya Sheth, Fakhar Ali Qazi Arisar, Rita Zaya, Maryam Naghibzadeh, Kai Duan, Sandra Elisabeth Fischer, Keyur Patel, Cynthia D Tsien et al. · 2023 · The Lancet Digital Health
32. Pharmacologic Therapies in Gastrointestinal Diseases
    Rena K. Fox, Thiruvengadam Muniraj · 2016 · Medical Clinics of North America
33. Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descent
    Sampath De Silva, Wenhao Li, Polychronis Kemos, James Hallimond Brindley, Jibran Mecci, Salma Samsuddin, Joanne Chin‐Aleong, Roger M. Feakins, Graham R. Foster, Wing‐Kin Syn et al. · 2017 · Frontline Gastroenterology
34. Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: Cross-sectional study in U.S. adults
    Toshihiro Umehara · 2018 · PLoS ONE
35. Noninvasive indices for monitoring disease course in Chinese patients with autoimmune hepatitis
    Tingting Zeng, Jianlin Yu, Liming Tan, Yang Wu, Yongjian Tian, Qiong Wu, Xingwang Duan, Le Yu · 2018 · Clinica Chimica Acta
36. Dynamic Evaluation of Liver Fibrosis to Assess the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C Who Achieved Sustained Virologic Response
    Hidenori Toyoda, Toshifumi Tada, Satoshi Yasuda, Kazuyuki Mizuno, Takanori Ito, Takashi Kumada · 2019 · Clinical Infectious Diseases
37. Noninvasive inflammatory markers for assessing liver fibrosis stage in autoimmune hepatitis patients
    Xiaoling Yuan, Sheng‐Zhong Duan, Junying Cao, Nan Gao, Jie Xu, Lanjing Zhang · 2019 · European Journal of Gastroenterology & Hepatology
38. Sofosbuvir‐containing regimens are safe and effective in the treatment of HCV patients with moderate to severe renal impairment
    Rasha Eletreby, Magdy El‐Serafy, Mahmoud Anees, Gamal Kasem, Marwa Salama, Reham Abdelkader Elkhouly, Mostafa Hamdy, Hisham Abdel-haleem Ali, Ehab Kamal, Wael Abdel‐Razek et al. · 2019 · Liver International
39. Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3/HIV co-infected patients
    M. Crespo Casal, Juan Ignacio Esteban, Esteban Ribera, Vicenç Falcó, Sílvia Sauleda, Marı́a Buti, Rafael Esteban, J Guàrdia, Imma Ocaña, Albert Pahissa · 2007 · AIDS
40. Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver disease
    Lina Gruneau, Stergios Kechagias, Per Sandström, Mattias Ekstedt, Martin Henriksson · 2023 · Hepatology Communications
41. Diagnostic accuracy of the Fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liver disease with type 2 diabetes: A systematic review and meta-analysis
    Ji Won Han, Hee Yeon Kim, Jung Hwan Yu, Mi Na Kim, Young Eun Chon, Jihyun An, Young‐Joo Jin, Miyoung Choi, Seung Up Kim, Han Ah Lee et al. · 2024 · Clinical and Molecular Hepatology
42. Association Between Noninvasive Liver Fibrosis Scores and Heart Failure in a General Population
    Xiao Liu, H T Zhang, Chang‐Chang Fang, Lin Li, Ze-Qun Lai, Ning‐Peng Liang, Xiang‐Tao Zhang, Min Wu, Xiaoping Yin, Huang Zhang et al. · 2024 · Journal of the American Heart Association
43. Liver Cirrhosis: Evolving Definitions, and Recent Advances in Diagnosis, Prevention and Management
    Andrew R. Battle, Julie Mudd, Golo Ahlenstiel, Eric Kalo · 2025 · Livers
44. Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study
    Giulia Carla Marchetti, Alessandro Cozzi‐Lepri, Camilla Tincati, Andrea Calcagno, Francesca Ceccherini‐Silberstein, Andrea De Luca, Andrea Antinori, Antonella Castagna, Massimo Puoti, Antonella d’Arminio Monforte · 2014 · BMC Infectious Diseases
45. Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B
    Jieyao Cheng, Jinlin Hou, Huiguo Ding, Guofeng Chen, Qing Xie, Yuming Wang, Minde Zeng, Xiaojuan Ou, Hong Ma, Jidong Jia · 2015 · PLoS ONE
46. Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon‐free versus interferon‐based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan
    Hidenori Toyoda, Toshifumi Tada, Koichi Takaguchi, Tomonori Senoh, N. Shimada, Atsushi Hiraoka, Kojiro Michitaka, Toru Ishikawa, Takashi Kumada · 2016 · Journal of Viral Hepatitis
47. Correlation between serum galectin‐9 levels and liver fibrosis
    Koji Fujita, Toshiro Niki, Takako Nomura, Kyoko Oura, Tomoko Tadokoro, Teppei Sakamoto, Joji Tani, Hirohito Yoneyama, Asahiro Morishita, Noriyuki Kuroda et al. · 2017 · Journal of Gastroenterology and Hepatology
48. Effect of Sofosbuvir Plus Daclatasvir in Hepatitis C Virus Genotype-4 Patients: Promising Effect on Liver Fibrosis
    Asmaa Mohamed Abdel‐Aziz, Mohamed A. Ibrahim, Azza A. K. El‐Sheikh, Maha Yehia Kamel, Nagwa M. Zenhom, Salam Abdel-Raheim, Hisham Abdelhaleem · 2017 · Journal of Clinical and Experimental Hepatology
49. Increasing Access to Hepatitis C Virus Medications: A Program Model Using Patient Navigators and Specialty Pharmacy to Obtain Prior Authorization Approval
    Trang M. Vu, Wilma Toribio, Farah Riazi, Genesis Ciprian, Nathalia Gibbs, Martha Giardina, Jocelyn A. Camacho, Korin E. Parrella, Joy Cambe, Catherine Amory et al. · 2018 · Journal of Managed Care & Specialty Pharmacy
50. Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology
    Tea Lund Laursen, Cecilie Siggaard Knoph, Konstantin Kazankov, Thomas Damgaard Sandahl, Holger Jon Møller, Adrian Ong, Mark W. Douglas, Jacob George, Britta Tarp, Lena Hagelskjær Kristensen et al. · 2018 · Scandinavian Journal of Gastroenterology
51. Proposed a simple score for recommendation of scheduled ultrasonography surveillance for hepatocellular carcinoma after Direct Acting Antivirals: multicenter analysis
    Atsushi Hiraoka, Takashi Kumada, Chikara Ogawa, Kazuya Kariyama, Masahiro Morita, Kazuhiro Nouso, Hidenori Toyoda, Toshifumi Tada, Marie Ochi, Taisei Murakami et al. · 2018 · Journal of Gastroenterology and Hepatology
52. Clinical implications of serum Mac-2-binding protein (M2BPGi) during regular follow-up of patients with biliary atresia
    Takehisa Ueno, Tasuku Kodama, Yuki Noguchi, Ryuta Saka, Yuichi Takama, Yuko Tazuke, Kazuhiko Bessho, Hiroomi Okuyama · 2018 · Pediatric Surgery International
53. Fibrosis Staging Using Direct Serum Biomarkers is Influenced by Hepatitis Activity Grading in Hepatitis C Virus Infection
    Koji Fujita, Noriyuki Kuroda, Asahiro Morishita, Kyoko Oura, Tomoko Tadokoro, Takako Nomura, Hirohito Yoneyama, Takeshi Arai, Takashi Himoto, Seishiro Watanabe et al. · 2018 · Journal of Clinical Medicine
54. Long‐term clinical outcomes in patients with autoimmune hepatitis according to treatment response in Asian country
    Jonggi Choi, Gwang Hyeon Choi, Danbi Lee, Ju Hyun Shim, Young‐Suk Lim, Han Chu Lee, Young–Hwa Chung, Yung-Sang Lee, Kang Mo Kim · 2019 · Liver International
55. Assessment of liver fibrosis using 2-dimensional shear wave elastography: a prospective study of intra- and inter-observer repeatability and comparison with point shear wave elastography
    Jeongin Yoo, Jeong Min Lee, Ijin Joo, Jeong Hee Yoon · 2019 · ULTRASONOGRAPHY
56. Slow walking speed overlapped with low handgrip strength in chronic liver disease patients with hepatocellular carcinoma
    Ayu Nagamatsu, Takumi Kawaguchi, Keisuke Hirota, Shunji Koya, Manabu Tomita, Ryuki Hashida, Yohei Kida, Hayato Narao, Yuta Manako, Daisuke Tanaka et al. · 2019 · Hepatology Research
57. Multiparametric MR Is a Valuable Modality for Evaluating Disease Severity of Nonalcoholic Fatty Liver Disease
    Young‐Sun Lee, Yang Jae Yoo, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, In Hee Kim, Soo Yeon Lee, Baek‐hui Kim, Jeong Woo Kim et al. · 2020 · Clinical and Translational Gastroenterology
58. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals
    Shereen Abo Baker Saleh, Mohamed Magdy Salama, Marwan M Alhusseini, Ghada Abdelrahman Mohamed · 2020 · World Journal of Gastroenterology
59. Non-invasive assessment of liver fibrosis in autoimmune hepatitis: Diagnostic value of liver magnetic resonance parametric mapping including extracellular volume fraction
    Narine Mesropyan, Patrick Arthur Kupczyk, Leona Dold, Tobias J. Weismüller, Alois Martin Sprinkart, Burkhard Mädler, Claus Christian Pieper, Daniel L. R. Kuetting, Christian P. Strassburg, Ulrike Irmgard Attenberger et al. · 2020 · Abdominal Radiology
60. Fibrosis-4 index as a predictor for mortality in hospitalised patients with COVID-19: a retrospective multicentre cohort study
    Jung Gil Park, Min Kyu Kang, Yu Rim Lee, Jeong Eun Song, Na Young Kim, Young Oh Kweon, Won Young Tak, Se Young Jang, Changhyeong Lee, Byung Seok Kim et al. · 2020 · BMJ Open
61. Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses
    Ryo Morisue, Motohiro Kojima, Toshihiro Suzuki, Tetsuya Nakatsura, Hidenori Ojima, Reiko Watanabe, Motokazu Sugimoto, Shin Kobayashi, Shinichiro Takahashi, Masaru Konishi et al. · 2021 · International Journal of Cancer
62. A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis
    J. Goet, C. F. Murillo Perez, M. Harms, A. Floreani, N. Cazzagon, Tony Bruns, F. Prechter, G. Dalekos, X. Verhelst, N. Gatselis et al. · 2021 · American Journal of Gastroenterology
63. Fibrosis-4 Index vs Nonalcoholic Fatty Liver Disease Fibrosis Score in Identifying Advanced Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease: A Meta-Analysis
    Marco Castellana, Rossella Donghia, Vito Guerra, Filippo Procino, Fabio Castellana, Roberta Zupo, Luisa Lampignano, Rodolfo Sardone, Giovanni De Pergola, Francesco Romanelli et al. · 2021 · The American Journal of Gastroenterology
64. Targeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment
    Xuejiao Chen, Ziyi Wang, Sheng Han, Zeng Wang, Yu Zhang, Xiangdong Li, Nan L. Xia, Wenjie Yu, Chenyang Jia, Yong Ni et al. · 2021 · Cell Death and Disease
65. Prognostic Value of the Liver Fibrosis Marker Fibrosis-5 Index in Patients with Acute Heart Failure
    Daichi Maeda, Yumiko Kanzaki, Kazushi Sakane, Kosuke Tsuda, Kanako Akamatsu, Ryoto Hourai, Takahiro Okuno, Daisuke Tokura, Sayuri Nakayama, Hitomi Hasegawa et al. · 2022 · ESC Heart Failure
66. The Utility and Diagnostic Accuracy of Transient Elastography in Adults with Morbid Obesity: A Prospective Study
    Ahmad Hassan Ali, Alhareth Al Juboori, Gregory F. Petroski, Alberto A. Diaz‐Arias, Majid Mufaqam Syed‐Abdul, Andrew A. Wheeler, Rama Ganga, James B. Pitt, Nicole Spencer, Ghassan M. Hammoud et al. · 2022 · Journal of Clinical Medicine
67. Non-invasive tests for liver fibrosis assessment in patients with chronic liver diseases: a prospective study
    Kessarin Thanapirom, Sirinporn Suksawatamnuay, Natthaporn Tanpowpong, Bundit Chaopathomkul, Supachaya Sriphoosanaphan, Panarat M. Thaimai, Nunthiya Srisoonthorn, Sombat Treeprasertsuk, Piyawat Komolmit · 2022 · Scientific Reports
68. Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients : what do we know so far ?
    Quentin Binet, Audrey Loumaye, Vanessa Preumont, Jean‐Paul Thissen, Michel Paul Hermans, Nicolas Lanthier · 2022 · Acta gastro-enterologica belgica
69. Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk
    Nuria Barbarroja, M. Ruiz-Ponce, Laura Cuesta-López, Carlos Pérez-Sánchez, Chary López-Pedrera, I. Arias de la Rosa, Eduardo Collantes‐Estévez · 2022 · Frontiers in Immunology
70. Prevalence, characteristics, and mortality outcomes of obese and nonobese MAFLD in the United States
    Allen Dao, Vy H. Nguyen, Takanori Ito, Ramsey C Cheung, Mindie H. Nguyen · 2022 · Hepatology International
71. SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT Forum
    Yoshihiro Kamada, Takahiro Nakamura, Satoko Isobe, Kumiko Hosono, Yukiko Suama, Yukie Ohtakaki, Arihito Nauchi, Naoto Yasuda, Soh Mitsuta, Kouichi Miura et al. · 2022 · Journal of Gastroenterology
72. Association of Serum Albumin Levels and Long-Term Prognosis in Patients with Biopsy-Confirmed Nonalcoholic Fatty Liver Disease
    Kazuhiro Takahashi, Miwa Kawanaka, Hideki Fujii, Michihiro Iwaki, Hideki Hayashi, Hidenori Toyoda, Satoshi Oeda, Hideyuki Hyogo, Asahiro Morishita, Kensuke Munekage et al. · 2023 · Nutrients
73. Impact of Hepatitis Coinfection on Healthcare Utilization Among Persons Living With HIV
    Trevor A. Crowell, Stephen A. Berry, John A. Fleishman, Richard W. LaRue, Philip Todd Korthuis, Ank E. Nijhawan, Richard D. Moore, Kelly A. Gebo · 2014 · JAIDS Journal of Acquired Immune Deficiency Syndromes
74. Steatosis Grade is the Most Important Risk Factor for Development of Endothelial Dysfunction in NAFLD
    Ferdane PİRİNÇÇİ SAPMAZ, Metın Uzman, Sebahat Başyığıt, Selçuk Özkan, Bünyamin Yavuz, Abdullah Özgür Yeniova, Ayşe Kefeli, Zeliha Asiltürk, Yaşar Nazlıgül · 2016 · Medicine
75. Altered Immunity and Microbial Dysbiosis in Aged Individuals With Long-Term Controlled HIV Infection
    Nicholas S. Rhoades, Norma Mendoza, Allen Jankeel, Suhas Sureshchandra, Alexander Delfin Alvarez, Brianna M. Doratt, Omeid Heidari, Rod Hagan, Brandon J. Brown, Steve Scheibel et al. · 2019 · Frontiers in Immunology
76. Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia/osteoporosis in T2DM patients
    Wei Zhang, Yuhua Li, Shangjian Li, Jingqi Zhou, Kai Wang, Zhibin Li, Ning Chen, Xueqin Chen · 2023 · Frontiers in Endocrinology
77. Machine Learning–Based Models for Advanced Fibrosis and Cirrhosis Diagnosis in Chronic Hepatitis B Patients With Hepatic Steatosis
    Fajuan Rui, Liang Xu, Yee Hui Yeo, Yayun Xu, Wenjing Ni, Youwen Tan, Qi Zheng, Xiaorong Tian, Qinglei Zeng, Zebao He et al. · 2024 · Clinical Gastroenterology and Hepatology
78. Advancements of non‐invasive imaging technologies for the diagnosis and staging of liver fibrosis: Present and future
    Wenpeng Huang, Yushuo Peng, Lei Kang · 2024 · Open Research (University of Surrey)
79. Endoscopic Ultrasound–Guided Portosystemic Pressure Gradient Correlates With Clinical Parameters and Liver Histology
    Jennifer M. Kolb, Marc Monachese, Raymond A. Rubin, Thomas J. Wang, Alyssa Y. Choi, Ahmad Najdat Bazarbashi, Bhaumik S. Brahmbhatt, Ali Zakaria, Pedro Cortés, Varun Kesar et al. · 2025 · Clinical Gastroenterology and Hepatology
80. Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease
    Jimmy Che‐To Lai, Boyu Yang, Hye Won Lee, Huapeng Lin, Emmanuel A. Tsochatzis, Salvatore Petta, Elisabetta Bugianesi, Masato Yoneda, Ming‐Hua Zheng, Hannes Hagström et al. · 2025 · Gut
81. Change in Fibrosis Score as a Predictor of Mortality Among HIV-Infected Patients with Viral Hepatitis
    Mamta K. Jain, Emmanuel Seremba, Rafia Bhore, Doan Y Dao, Reeti Joshi, Nahid Attar, He-Jun Yuan, William M. Lee · 2012 · AIDS Patient Care and STDs
82. Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co‐infection
    Santiago Moreno, Javier García‐Samaniego, Ana Maria Moreno, E. Ortega, Juan Antonio Pineda, J. Del Romero, Cristina Tural, M. A. von Wichmann, Juan Berenguer, Á. Castro et al. · 2009 · Journal of Viral Hepatitis
83. Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study
    Helen Kovari, Caroline Anne Sabin, Bruno Ledergerber, Lene Ryom, Peter Reiss, Matthew G. Law, Christian Pradier, François Dabis, Antonella d’Arminio Monforte, Colette J Smith et al. · 2016 · Open Forum Infectious Diseases
84. Liver Fibrosis Regression Measured by Transient Elastography in Human Immunodeficiency Virus (HIV)-Hepatitis B Virus (HBV)-Coinfected Individuals on Long-Term HBV-Active Combination Antiretroviral Therapy
    Jennifer Audsley, Christopher Robson, Stacey Aitchison, Gail V. Matthews, David M. Iser, Joe J Sasadeusz, Sharon R. Lewin · 2016 · Open Forum Infectious Diseases
85. Targeting Hepatic Fibrosis in Autoimmune Hepatitis
    Aldo J. Montaño‐Loza, Ragesh B. Thandassery, Albert J. Czaja · 2016 · Digestive Diseases and Sciences
86. Liver Fibrosis and Body Mass Index Predict Hepatocarcinogenesis following Eradication of Hepatitis C Virus RNA by Direct-Acting Antivirals
    Norio Akuta, Masahiro Kobayashi, Fumitaka Suzuki, Hitomi Sezaki, Shunichiro Fujiyama, Yusuke Kawamura, Tetsuya Hosaka, Mariko Kobayashi, Satoshi Saitoh, Yoshiyuki Suzuki et al. · 2016 · Oncology
87. Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients
    Patrizia Carrieri, Camélia Protopopescu, Fabienne Marcellin, Silvia Rosellini, Linda Wittkop, Laure Esterle, David Zucman, François Raffi, É. Rosenthal, Isabelle Poizot‐Martin et al. · 2017 · Journal of Hepatology
88. Hepatic Parenchymal Injury in Crigler‐Najjar Type I
    Ellen L. Mitchell, Sarangarajan Ranganathan, Patrick James McKiernan, Robert H. Squires, Kevin A. Strauss, Kyle A Soltys, George Vincent Mazariegos, James E. Squires · 2017 · Journal of Pediatric Gastroenterology and Nutrition
89. Predictive value of the red blood cell distribution width-to-platelet ratio for hepatic fibrosis
    Ding Yuyun, Tao Zhihua, Wang Haijun, Liao Zhaoping, Zhu Xiaoli, Wenfang Xu, Jin FaXiang, Hongmei Liu · 2019 · Scandinavian Journal of Gastroenterology
90. Expanding the Liver Imaging Reporting and Data System (LI-RADS) v2018 diagnostic population: performance and reliability of LI-RADS for distinguishing hepatocellular carcinoma (HCC) from non-HCC primary liver carcinoma in patients who do not meet strict LI-RADS high-risk criteria
    Daniel R. Ludwig, Tyler J. Fraum, Roberto Cannella, Richard Tsai, Muhammad Naeem, Maverick LeBlanc, Amber R. Salter, Allan Tsung, Jaquelyn Fleckenstein, Anup S. Shetty et al. · 2019 · HPB
91. Real‐world experience of 12‐week direct‐acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection
    Hidenori Toyoda, Masanori Atsukawa, Tsunamasa Watanabe, Makoto Nakamuta, Haruki Uojima, Akito Nozaki, Koichi Takaguchi, Shinichi Fujioka, Etsuko Iio, Toshihide Shima et al. · 2019 · Journal of Gastroenterology and Hepatology
92. HIV RNA, CD4+ Percentage, and Risk of Hepatocellular Carcinoma by Cirrhosis Status
    Jessie Torgersen, Michael J. Kallan, Dena M. Carbonari, Lesley S. Park, Rajni L. Mehta, Kathryn D’Addeo, Janet P. Tate, Joseph K. Lim, Matthew Bidwell Goetz, Maria C. Rodriguez‐Barradas et al. · 2019 · JNCI Journal of the National Cancer Institute
93. Liver function tests and fibrosis scores in a rural population in Africa: a cross-sectional study to estimate the burden of disease and associated risk factors
    Geraldine A. O’Hara, Jolynne Mokaya, Jeffrey P. Hau, Louise Downs, Anna L. McNaughton, Alex Karabarinde, Gershim Asiki, Janet Seeley, Philippa Clare Matthews, Robert Newton · 2020 · BMJ Open
94. Prevalence of NASH/NAFLD in people with obesity who are currently classified as metabolically healthy
    Sébastien Frey, Stéphanie Patouraux, Tarek Debs, Jean Gugenheim, Rodolphe Anty, Antonio Iannelli · 2020 · Surgery for Obesity and Related Diseases
95. Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
    Chen‐Hua Liu, Po-Yueh Chen, Jyh-Jou Chen, Gin‐Ho Lo, Wei‐Wen Su, Kuo‐Chih Tseng, Chun‐Jen Liu, Chia-Sheng Huang, Ke-Jhang Huang, Sheng‐Shun Yang et al. · 2021 · Hepatology International
96. Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019
    Feng Gao, Kenneth I. Zheng, Huadong Yan, Qing-Feng Sun, Ke-Hua Pan, Ting-Yao Wang, Yong-Ping Chen, G. Targher, C. Byrne, J. George et al. · 2021 · Frontiers in Endocrinology
97. Advanced liver fibrosis and the metabolic syndrome in a primary care setting
    Andrew D. Schreiner, Jingwen Zhang, Valerie L. Durkalski‐Mauldin, Sherry Livingston, Justin E. Marsden, John Bian, Patrick D. Mauldin, William P. Moran, Don C. Rockey · 2021 · Diabetes/Metabolism Research and Reviews
98. Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials
    Wong, Vincent Wai-Sun, Tak, Won Young, Goh, George Boon Bee, Cheng, Pin-Nan, Lawitz, Eric J., Younossi, Zobair M., Vuppalanchi, Raj, Younes, Ziad, Alkhouri, Naim, Wang, Lulu et al. · 2023 · Clinical Gastroenterology and Hepatology
99. Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date
    Albhaisi, Somaya, Sanyal, Arun J. · 2019 · Pharmaceutical Medicine
100. Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells
     D'Avola, Delia, Fernández-Ruiz, Verónica, Carmona-Torre, Francisco, Méndez, Miriam, Pérez-Calvo, Javier, Prósper, Felipe, Andreu, Enrique, Herrero, José Ignacio, Iñarrairaegui, Mercedes, Fuertes, Carmen et al. · 2017 · Translational Research